The city of Austin, Texas, currently has 2 active clinical trials seeking participants for Atopic Dermatitis research studies.
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Gender:
All
Ages:
Between 12 years and 100 years
Trial Updated:
06/19/2024
Locations: US Dermatology Partners Jollyville, Austin, Texas
Conditions: Atopic Dermatitis
Study of TDM-180935 in Atopic Dermatitis Patients
Recruiting
Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopic Dermatitis Patients
Gender:
All
Ages:
18 years and above
Trial Updated:
04/26/2024
Locations: Site 3, Austin, Texas
Conditions: Atopic Dermatitis